I-Palbociclib CAS 571190-30-2 Purity >99.5% (HPLC) API Factory
I-Ruifu Chemical Supply Palbociclib Related Intermediate:
I-Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidine CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl)piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-Pyridyl)piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-one CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-Pyrido[2,3-d]pyrimidin-7-one CAS 1013916-37-4
Igama Lekhemikhali | I-Palbociclib |
Omqondofana | PD-0332991;Otava-Bb 1115529;Ibrance |
Inombolo ye-CAS | 571190-30-2 |
Isimo Sesitoko | Esitokweni, Isikali Sokukhiqiza Sifinyelela Kumathani |
I-Molecular Formula | I-C24H29N7O2 |
Isisindo samangqamuzana | 447.54 |
Ibhrendi | I-Ruifu Chemical |
Into | Imininingwane |
Ukubukeka | Impushana Emhlophe noma Engamhlophe |
1H NMR Spectrum | Ihambisana Nesakhiwo |
I-HPLC | Ihambisana Nesakhiwo |
Izinto Ezihlobene | |
Ukungcola Ngamunye | <0.50% |
Ukungcola Okuphelele | <1.00% |
Ukulahlekelwa Ekumisweni | <0.50% |
Izinsalela ekushiseni | <0.10% |
Izinsimbi Ezisindayo | <10ppm |
Ukuhlanzeka / Indlela Yokuhlaziya | >99.5% (HPLC) |
Izinga Lokuhlola | I-Enterprise Standard |
Ukusetshenziswa | I-API, Ekwelapheni Umdlavuza Webele |
Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, 25kg/Cardboard Drum, noma ngokwemfuneko yekhasimende
Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni nakumswakama
I-Palbociclib (i-CAS: 571190-30-2) iyi-inhibitor etholakala ngomlomo ye-cyclin-dependent kinase (CDK) enomsebenzi ongaba khona we-antineoplastic.I-Palbociclib ivimbela ngokukhethayo i-cyclin-dependent kinase 4 (CDK4) kanye ne-6 (CDK6), ngaleyo ndlela ivimbele i-retinoblastoma (Rb) iphrotheni phosphorylation ekuqaleni kwesigaba se-G1 okuholela ekuboshweni komjikelezo weseli.Lokhu kucindezela ukuphindaphinda kwe-DNA futhi kunciphisa ukwanda kwamaseli e-tumor.I-Palbociclib ingummeleli wokuqala wesigaba esisha somuthi we-cyclin-dependent kinase inhibitors.Lo mphumela ukhawulela ukwanda kwamaseli (ukukhula kwamaseli nokuhlukana).Isetshenziswa njenge-antineoplastic ejenti kumdlavuza webele othuthukile noma we-metastatic.